Grant: Operating Grant
University of Toronto
$276,484.00
Novel Nitric Oxide Delivery System for Wound Healing
FY 2010-11
Summary
Diabetic foot ulcers are a leading cause of amputations in diabetes patients. An effective therapy for treating chronic diabetic foot ulcers is still lacking. Nitric oxide (NO), a critical mediator in normal tissue repair, has been shown to play a pivotal role in the overall wound healing process. Several studies have linked impaired wound healing in diabetic ulcer patients to NO deficiencies at the wound site. Topical administration of NO or NO donors has been shown to promote tissue repair and healing of diabetic ulcers in animal models. However, existing avenues for NO delivery have major challenges regarding the safety of the nitric oxide donor system. Also, the short half life of NO makes it is necessary to deliver NO at optimal concentrations over a long enough period of time to maximize therapeutic effectiveness. Most systems exhaust their NO load in hours, too quick for optimal wound healing in diabetic ulcers. To overcome these, we have developed a simple, stable and biocompatible system which can release NO over an extended period of time (>9 days). This is based on the discovery that immobilizing S-nitrosoglutathione (GSNO), a short-lived endogenous NO donor, onto a polymer complex greatly enhances the stability of GSNO and provides controlled NO release for an extended time not achieved by most existing systems. Preliminary test in a diabetic rat model suggests that a single topical application of this system can potentially accelerate wound closure. We propose to further study critical design parameters affecting the performance of this delivery system. Animal studies will be carried out in a diabetic animal model to demonstrate efficacy and improved quality of healed wound through histology assessment. Results obtained will help the design of more effective NO delivery systems for enhancing diabetic wound healing and should have a significant impact on the health care system by reducing the need for amputations in millions of diabetic ulcer patients.
Department
Program
Operating Grant
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
224096
Name
Lee Ping I
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Biomedical Engineering
Projecttitle
Novel Nitric Oxide Delivery System for Wound Healing
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$276,484
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Critical Design Parameters Affecting No Delivery Properties; Enhanced Wound Healing In A Diabetic Animal Model; Mechanisms Of Nitric Oxide Release From The Present System; New Supramacromolecular Complexes For Extended Release Of No; Optimization Of Nitric Oxide Loading And Release; Study Of Various Physical Forms Of The Present Complexes
Abstract
Diabetic foot ulcers are a leading cause of amputations in diabetes patients. An effective therapy for treating chronic diabetic foot ulcers is still lacking. Nitric oxide (NO), a critical mediator in normal tissue repair, has been shown to play a pivotal role in the overall wound healing process. Several studies have linked impaired wound healing in diabetic ulcer patients to NO deficiencies at the wound site. Topical administration of NO or NO donors has been shown to promote tissue repair and healing of diabetic ulcers in animal models. However, existing avenues for NO delivery have major challenges regarding the safety of the nitric oxide donor system. Also, the short half life of NO makes it is necessary to deliver NO at optimal concentrations over a long enough period of time to maximize therapeutic effectiveness. Most systems exhaust their NO load in hours, too quick for optimal wound healing in diabetic ulcers. To overcome these, we have developed a simple, stable and biocompatible system which can release NO over an extended period of time (>9 days). This is based on the discovery that immobilizing S-nitrosoglutathione (GSNO), a short-lived endogenous NO donor, onto a polymer complex greatly enhances the stability of GSNO and provides controlled NO release for an extended time not achieved by most existing systems. Preliminary test in a diabetic rat model suggests that a single topical application of this system can potentially accelerate wound closure. We propose to further study critical design parameters affecting the performance of this delivery system. Animal studies will be carried out in a diabetic animal model to demonstrate efficacy and improved quality of healed wound through histology assessment. Results obtained will help the design of more effective NO delivery systems for enhancing diabetic wound healing and should have a significant impact on the health care system by reducing the need for amputations in millions of diabetic ulcer patients.
Competitiondate
201103
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lee, Ping I
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $276,484~ $0~